BLB-101(Beijing Libang)
N/A
Report date: 2023/07/14 15:45:42
Base Information
Drug NameBLB-101(Beijing Libang)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Libang Biomedical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Libang Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A